8,188
Views
20
CrossRef citations to date
0
Altmetric
Review

How valvular calcification can affect the outcomes of transcatheter aortic valve implantation

ORCID Icon, & ORCID Icon
Pages 773-784 | Received 10 Apr 2020, Accepted 26 Jun 2020, Published online: 13 Jul 2020

References

  • Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010 Oct 21;363(17):1597–1607.
  • Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011 Jun 9;364(23):2187–2198.
  • Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016 Apr 28;374(17):1609–1620.
  • Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019 May 2;380(18):1695–1705.
  • Waksman R, Rogers T, Torguson R, et al. Transcatheter aortic valve replacement in low-risk patients with symptomatic severe aortic stenosis. J Am Coll Cardiol. 2018 Oct 30;72(18):2095–2105.
  • Bax JJ, Delgado V, Bapat V, et al. Open issues in transcatheter aortic valve implantation. Part 2: procedural issues and outcomes after transcatheter aortic valve implantation. Eur Heart J. 2014 Oct 7;35(38):2639–2654.
  • Barbanti M, Gulino S, Costa G, et al. Pathophysiology, incidence and predictors of conduction disturbances during transcatheter aortic valve implantation. Expert Rev Med Devices. 2017 Feb;14(2):135–147.
  • Girdauskas E, Owais T, Fey B, et al. Subannular perforation of left ventricular outflow tract associated with transcatheter valve implantation: pathophysiological background and clinical implications. Eur J Cardio-thorac Surg. 2017 Jan;51(1):91–96.
  • Ribeiro HB, Webb JG, Makkar RR, et al. Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry. J Am Coll Cardiol. 2013 Oct 22;62(17):1552–1562.
  • Zamorano J, Goncalves A, Lancellotti P, et al. The use of imaging in new transcatheter interventions: an EACVI review paper. Eur Heart J Cardiovasc Imaging. 2016 Aug;17(8):835–835af.
  • Achenbach S, Delgado V, Hausleiter J, et al. SCCT expert consensus document on computed tomography imaging before transcatheter aortic valve implantation (TAVI)/transcatheter aortic valve replacement (TAVR). J Cardiovasc Comput Tomogr. 2012 Nov-Dec;6(6):366–380.
  • Pawade T, Sheth T, Guzzetti E, et al. Why and how to measure aortic valve calcification in patients with aortic stenosis. JACC Cardiovasc Imaging. 2019 Sep;12(9):1835–1848.
  • Clavel MA, Pibarot P, Messika-Zeitoun D, et al. Impact of aortic valve calcification, as measured by MDCT, on survival in patients with aortic stenosis: results of an international registry study. J Am Coll Cardiol. 2014 Sep 23;64(12):1202–1213.
  • Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017 Sep 21;38(36):2739–2791.
  • Blanke P, Weir-McCall JR, Achenbach S, et al. Computed Tomography Imaging in the Context of Transcatheter Aortic Valve Implantation (TAVI)/Transcatheter Aortic Valve Replacement (TAVR): an expert consensus document of the society of cardiovascular computed tomography. JACC Cardiovasc Imaging. 2019 Jan;12(1):1–24.
  • Dvir D, Barbash IM, Ben-Dor I, et al. Paravalvular regurgitation after transcatheter aortic valve replacement: diagnosis, clinical outcome, preventive and therapeutic strategies. Cardiovasc Revascularization Med incl Mol Interventions. 2013 May-Jun;14(3):174–181.
  • Sinning JM, Werner N, Nickenig G, et al. Transcatheter aortic valve implantation: upcoming new devices. Interv Cardiol Clin. 2012 Jan;1(1):37–43.
  • Webb JG, Wood DA. Current status of transcatheter aortic valve replacement. J Am Coll Cardiol. 2012 Aug 7;60(6):483–492.
  • Tamburino C, Capodanno D, Ramondo A, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation. 2011 Jan 25;123(3):299–308.
  • Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012 May 3;366(18):1686–1695.
  • Gilard M, Eltchaninoff H, Iung B, et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med. 2012 May 3;366(18):1705–1715.
  • Hayashida K, Lefevre T, Chevalier B, et al. Impact of post-procedural aortic regurgitation on mortality after transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2012 Dec;5(12):1247–1256.
  • Gotzmann M, Korten M, Bojara W, et al. Long-term outcome of patients with moderate and severe prosthetic aortic valve regurgitation after transcatheter aortic valve implantation. Am J Cardiol. 2012 Nov 15;110(10):1500–1506.
  • Athappan G, Patvardhan E, Tuzcu EM, et al. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J Am Coll Cardiol. 2013 Apr 16;61(15):1585–1595.
  • Ewe SH, Ng AC, Schuijf JD, et al. Location and severity of aortic valve calcium and implications for aortic regurgitation after transcatheter aortic valve implantation. Am J Cardiol. 2011 Nov 15;108(10):1470–1477.
  • Feuchtner G, Plank F, Bartel T, et al. Prediction of paravalvular regurgitation after transcatheter aortic valve implantation by computed tomography: value of aortic valve and annular calcification. Ann Thorac Surg. 2013 Nov;96(5):1574–1580.
  • Koos R, Mahnken AH, Dohmen G, et al. Association of aortic valve calcification severity with the degree of aortic regurgitation after transcatheter aortic valve implantation. Int J Cardiol. 2011 Jul 15;150(2):142–145.
  • Haensig M, Lehmkuhl L, Rastan AJ, et al. Aortic valve calcium scoring is a predictor of significant paravalvular aortic insufficiency in transapical-aortic valve implantation. Eur J Cardio-thorac Surg. 2012 Jun;41(6):1234–1240. discussion 1240-1.
  • John D, Buellesfeld L, Yuecel S, et al. Correlation of device landing zone calcification and acute procedural success in patients undergoing transcatheter aortic valve implantations with the self-expanding corevalve prosthesis. JACC Cardiovasc Interv. 2010 Feb;3(2):233–243.
  • Schultz CJ, Tzikas A, Moelker A, et al. Correlates on MSCT of paravalvular aortic regurgitation after transcatheter aortic valve implantation using the Medtronic CoreValve prosthesis. Catheter Cardiovasc Interv. 2011 Sep 1;78(3):446–455.
  • Mauri V, Deuschl F, Frohn T, et al. Predictors of paravalvular regurgitation and permanent pacemaker implantation after TAVR with a next-generation self-expanding device. Clin Res Cardiol. 2018 Aug;107(8):688–697.
  • Pollari F, Grossmann I, Vogt F, et al. Risk factors for atrioventricular block after transcatheter aortic valve implantation: a single-centre analysis including assessment of aortic calcifications and follow-up. Europace. 2019 Jan 9;21(5):787–795.
  • Unbehaun A, Pasic M, Dreysse S, et al. Transapical aortic valve implantation: incidence and predictors of paravalvular leakage and transvalvular regurgitation in a series of 358 patients. J Am Coll Cardiol. 2012 Jan 17;59(3):211–221.
  • Colli A, D’Amico R, Kempfert J, et al. Transesophageal echocardiographic scoring for transcatheter aortic valve implantation: impact of aortic cusp calcification on postoperative aortic regurgitation. J Thorac Cardiovasc Surg. 2011 Nov;142(5):1229–1235.
  • Pavicevic J, Nguyen TD, Caliskan E, et al. Aortic valve calcium score is a significant predictor for the occurrence of post-interventional paravalvular leakage after transcatheter aortic valve implantation - Results from a single center analysis of 260 consecutive patients. Int J Cardiol. 2015 Feb 15;181:185–187.
  • Delgado V, Ng AC, van de Veire NR, et al. Transcatheter aortic valve implantation: role of multi-detector row computed tomography to evaluate prosthesis positioning and deployment in relation to valve function. Eur Heart J. 2010 May;31(9):1114–1123.
  • Koh EY, Lam KY, Bindraban NR, et al. Aortic valve calcification as a predictor of location and severity of paravalvular regurgitation after transcatheter aortic valve implantation. Interact Cardiovasc Thorac Surg. 2015 Mar;20(3):345–350.
  • Mihara H, Shibayama K, Berdejo J, et al. Impact of device landing zone calcification on paravalvular regurgitation after transcatheter aortic valve replacement: a real-time three-dimensional transesophageal echocardiographic study. J Am Soc Echocardiogr. 2015 Apr;28(4):404–414.
  • Abramowitz Y, Jilaihawi H, Chakravarty T, et al. Balloon-expandable transcatheter aortic valve replacement in patients with extreme aortic valve calcification. Catheter Cardiovasc Interv. 2016 May;87(6):1173–1179.
  • Akodad M, Lattuca B, Agullo A, et al. Prognostic impact of calcium score after transcatheter aortic valve implantation performed with new generation prosthesis. Am J Cardiol. 2018 May 15;121(10):1225–1230.
  • Guimarães L, Ferreira-Neto AN, Urena M, et al. Transcatheter aortic valve replacement with the balloon-expandable SAPIEN 3 valve: impact of calcium score on valve performance and clinical outcomes. Int J Cardiol. 2020 May 1;306:20–24.
  • Al-Azzam F, Greason KL, Krittanawong C, et al. The influence of native aortic valve calcium and transcatheter valve oversize on the need for pacemaker implantation after transcatheter aortic valve insertion. J Thorac Cardiovasc Surg. 2017 May;153(5):1056–1062.e1.
  • Latsios G, Gerckens U, Buellesfeld L, et al. “Device landing zone” calcification, assessed by MSCT, as a predictive factor for pacemaker implantation after TAVI. Catheter Cardiovasc Interv. 2010 Sep 1;76(3):431–439.
  • Fujita B, Kutting M, Seiffert M, et al. Calcium distribution patterns of the aortic valve as a risk factor for the need of permanent pacemaker implantation after transcatheter aortic valve implantation. Eur Heart J Cardiovasc Imaging. 2016 Dec;17(12):1385–1393.
  • Leipsic J, Yang TH, Min JK. Computed tomographic imaging of transcatheter aortic valve replacement for prediction and prevention of procedural complications. Circ Cardiovasc Imaging. 2013 Jul;6(4):597–605.
  • Pasic M, Unbehaun A, Dreysse S, et al. Rupture of the device landing zone during transcatheter aortic valve implantation: a life-threatening but treatable complication. Circ Cardiovasc Interventions. 2012 Jun;5(3):424–432.
  • Tsuru Y, Miura M, Shirai S, et al. Aortic complex rupture after transcatheter aortic valve implantation. Int Heart J. 2019 May;60(3):772–777.
  • Pasic M, Unbehaun A, Buz S, et al. Annular rupture during transcatheter aortic valve replacement: classification, pathophysiology, diagnostics, treatment approaches, and prevention. JACC Cardiovasc Interv. 2015 Jan;8(1 Pt A):1–9.
  • Hansson NC, Norgaard BL, Barbanti M, et al. The impact of calcium volume and distribution in aortic root injury related to balloon-expandable transcatheter aortic valve replacement. J Cardiovasc Comput Tomogr. 2015 Sep-Oct;9(5):382–392.
  • Barbanti M, Yang TH, Rodes Cabau J, et al. Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement. Circulation. 2013 Jul 16;128(3):244–253.
  • Kiriyama H, Kaneko H, Itoh H, et al. Left main coronary artery obstruction by huge noncoronary cusp calcification after transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2019 Jul;12(13):1285–1287.
  • Ribeiro HB, Nombela-Franco L, Urena M, et al. Coronary obstruction following transcatheter aortic valve implantation: a systematic review. JACC Cardiovasc Interv. 2013 May;6(5):452–461.
  • Akinseye OA, Jha SK, Ibebuogu UN. Clinical outcomes of coronary occlusion following transcatheter aortic valve replacement: A systematic review. Cardiovasc Revascularization Med incl Mol Interventions. 2018 Mar;19(2):229–236.
  • Nombela-Franco L, Webb JG, de Jaegere PP, et al. Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation. Circulation. 2012 Dec 18;126(25):3041–3053.
  • Aggarwal SK, Rn N D, Menezes LJ, et al. Patterns of solid particle embolization during transcatheter aortic valve implantation and correlation with aortic valve calcification. J Interv Cardiol. 2018 Oct;31(5):648–654.
  • Doerner J, Kupczyk PA, Wilsing M, et al. Cerebral white matter lesion burden is associated with the degree of aortic valve calcification and predicts peri-procedural cerebrovascular events in patients undergoing transcatheter aortic valve implantation (TAVI). Catheter Cardiovasc Interv. 2018 Mar 1;91(4):774–782.
  • Pollari F, Hitzl W, Vogt F, et al. Aortic valve calcification as a risk factor for major complications and reduced survival after transcatheter replacement. J Cardiovasc Comput Tomogr. 2019 Dec 7. DOI:10.1016/j.jcct.2019.12.001.
  • Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017 Apr 6;376(14):1321–1331.
  • Makkar RR, Thourani VH, Mack MJ, et al. Five-year outcomes of transcatheter or surgical aortic-valve replacement. N Engl J Med. 2020 Feb 27;382(9):799–809.
  • Mc Morrow R, Kriza C, Urbán P, et al. Assessing the safety and efficacy of TAVR compared to SAVR in low-to-intermediate surgical risk patients with aortic valve stenosis: an overview of reviews. Int J Cardiol. 2020 Apr 11;314:43–53.
  • Kolkailah AA, Doukky R, Pelletier MP, et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis in people with low surgical risk. Cochrane Database Syst Rev. 2019 Dec 20;12(12):Cd013319.
  • Elgendy IY, Gad MM, Mahmoud AN, et al. Meta-analysis comparing outcomes of self-expanding versus balloon-expandable valves for transcatheter aortic valve implantation. Am J Cardiol. 2020 May 16. DOI:10.1016/j.amjcard.2020.05.007.
  • Thiele H, Kurz T, Feistritzer HJ, et al. Comparison of newer generation self-expandable vs. balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial. Eur Heart J. 2020 May 21;41(20):1890–1899.
  • Kapadia SR, Kodali S, Makkar R, et al. Protection against cerebral embolism during transcatheter aortic valve replacement. J Am Coll Cardiol. 2017 Jan 31;69(4):367–377.
  • Ghanem A, Müller A, Nähle CP, et al. Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging. J Am Coll Cardiol. 2010 Apr 6;55(14):1427–1432.
  • Kahlert P, Knipp SC, Schlamann M, et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation. 2010 Feb 23;121(7):870–878.
  • Fairbairn TA, Mather AN, Bijsterveld P, et al. Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: assessment of predictive risk factors and the relationship to subsequent health status. Heart. 2012 Jan;98(1):18–23.
  • Spaziano M, Francese DP, Leon MB, et al. Imaging and functional testing to assess clinical and subclinical neurological events after transcatheter or surgical aortic valve replacement: a comprehensive review. J Am Coll Cardiol. 2014 Nov 4;64(18):1950–1963.
  • Schmidt T, Leon MB, Mehran R, et al. Debris heterogeneity across different valve types captured by a cerebral protection system during transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2018 Jul 9;11(13):1262–1273.
  • Van Mieghem NM, van Gils L, Ahmad H, et al. Filter-based cerebral embolic protection with transcatheter aortic valve implantation: the randomised MISTRAL-C trial. EuroIntervention. 2016 Jul 20;12(4):499–507.
  • Haussig S, Mangner N, Dwyer MG, et al. Effect of a cerebral protection device on brain lesions following transcatheter aortic valve implantation in patients with severe aortic stenosis: the CLEAN-TAVI randomized clinical trial. Jama. 2016 Aug 9;316(6):592–601.
  • Hamm CW, Arsalan M, Mack MJ. The future of transcatheter aortic valve implantation. Eur Heart J. 2016 Mar 7;37(10):803–810.
  • Abramowitz Y, Jilaihawi H, Pibarot P, et al. Severe aortic stenosis with low aortic valve calcification: characteristics and outcome following transcatheter aortic valve implantation. Eur Heart J Cardiovasc Imaging. 2017 Jun 1;18(6):639–647.
  • Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014 May 8;370(19):1790–1798.
  • Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019 May 2;380(18):1706–1715.
  • Boskovski MT, Nguyen TC, McCabe JM, et al. Outcomes of transcatheter aortic valve replacement in patients with severe aortic stenosis: a review of a disruptive technology in aortic valve surgery. JAMA Surg. 2019 Nov 27. doi: 10.1001/jamasurg.2019.4449
  • Ludwig S, Goßling A, Waldschmidt L, et al. TAVR for low-flow, low-gradient aortic stenosis: prognostic impact of aortic valve calcification. Am Heart J. 2020 Jul;225:138-148.
  • Zegdi R, Blanchard D, Azarine A, et al. Elliptical shape of a SAPIEN XT prosthesis deployed in a patient with bicuspid aortic valve stenosis. J Heart Valve Dis. 2012 Nov;21(6):764–766.
  • Zegdi R, Ciobotaru V, Noghin M, et al. Is it reasonable to treat all calcified stenotic aortic valves with a valved stent? Results from a human anatomic study in adults. J Am Coll Cardiol. 2008 Feb 5;51(5):579–584.
  • Mahadevia R, Barker AJ, Schnell S, et al. Bicuspid aortic cusp fusion morphology alters aortic three-dimensional outflow patterns, wall shear stress, and expression of aortopathy. Circulation. 2014 Feb 11;129(6):673–682.
  • Jilaihawi H, Chen M, Webb J, et al. A bicuspid aortic valve imaging classification for the TAVR era. JACC Cardiovasc Imaging. 2016 Oct;9(10):1145–1158.
  • Ferda J, Linhartova K, Kreuzberg B. Comparison of the aortic valve calcium content in the bicuspid and tricuspid stenotic aortic valve using non-enhanced 64-detector-row-computed tomography with prospective ECG-triggering. Eur J Radiol. 2008 Dec;68(3):471–475.
  • Watanabe Y, Chevalier B, Hayashida K, et al. Comparison of multislice computed tomography findings between bicuspid and tricuspid aortic valves before and after transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2015 Aug;86(2):323–330.
  • Das R, Puri R. Transcatheter treatment of bicuspid aortic valve disease: imaging and interventional considerations. Front Cardiovasc Med. 2018;5:91.
  • Mylotte D, Lefevre T, Sondergaard L, et al. Transcatheter aortic valve replacement in bicuspid aortic valve disease. J Am Coll Cardiol. 2014 Dec 9;64(22):2330–2339.
  • Thyregod HG, Steinbruchel DA, Ihlemann N, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial. J Am Coll Cardiol. 2015 May 26;65(20):2184–2194.
  • Spitzer E, Ren B, Kroon H, et al. Moderate aortic stenosis and reduced left ventricular ejection fraction: current evidence and challenges ahead. Front Cardiovasc Med. 2018;5:111.
  • Meredith Am IT, Walters DL, Dumonteil N, et al. Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II study. J Am Coll Cardiol. 2014 Sep 30;64(13):1339–1348.
  • Falk V, Wöhrle J, Hildick-Smith D, et al. Safety and efficacy of a repositionable and fully retrievable aortic valve used in routine clinical practice: the RESPOND study. Eur Heart J. 2017 Dec 1;38(45):3359–3366.